Selected research
Industry Growth & Trends
Global Loratadine API Industry Growth and Trends Forecast to 2032
Market perspective
The global Loratadine API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Loratadine API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Loratadine API include Shenzhen Salubris Pharmaceuticals, Shenzhen Haibin Pharmaceutical, Merck Group, Mylan, Shaanxi Hanjiang, Changzhou Yabang, Changzhou Fangyuan Pharmaceutical, Vasudha Pharma Chem and Ultratech India Limited, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Loratadine API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Loratadine API market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Loratadine API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Loratadine API.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Loratadine API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Loratadine API Market by Company
Shenzhen Salubris Pharmaceuticals
Shenzhen Haibin Pharmaceutical
Merck Group
Mylan
Shaanxi Hanjiang
Changzhou Yabang
Changzhou Fangyuan Pharmaceutical
Vasudha Pharma Chem
Ultratech India Limited
Morepen
Inke, S.A.
Hetero Drugs Ltd
Cadila Pharmaceuticals
Argon Drugs
Loratadine API Segment by Type
Pharmaceutical Standards Grade
EP Standards Grade
USP Standards Grade
Others
Loratadine API Segment by Application
Loratadine Syrup
Loratadine Tablet
Loratadine Capsules
Dry Suspension
Others
Loratadine API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Loratadine API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Loratadine API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Loratadine API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Loratadine API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Loratadine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Pharmaceutical Standards Grade
- EP Standards Grade
- USP Standards Grade
- Others
Applications
- Loratadine Syrup
- Loratadine Tablet
- Loratadine Capsules
- Dry Suspension
- Others
Companies covered
- Shenzhen Salubris Pharmaceuticals
- Shenzhen Haibin Pharmaceutical
- Merck Group
- Mylan
- Shaanxi Hanjiang
- Changzhou Yabang
- Changzhou Fangyuan Pharmaceutical
- Vasudha Pharma Chem
- Ultratech India Limited
- Morepen
- Inke, S.A.
- Hetero Drugs Ltd
- Cadila Pharmaceuticals
- Argon Drugs
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Loratadine API Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Loratadine API Sales Estimates and Forecasts (2021-2032)
- 1.3 Loratadine API Market by Type
- 1.3.1 Pharmaceutical Standards Grade
- 1.3.2 EP Standards Grade
- 1.3.3 USP Standards Grade
- 1.3.4 Others
- 1.4 Global Loratadine API Market Size by Type
- 1.4.1 Global Loratadine API Market Size Overview by Type (2021-2032)
- 1.4.2 Global Loratadine API Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Loratadine API Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Loratadine API Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Loratadine API Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Loratadine API Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Loratadine API Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Loratadine API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Loratadine API Industry Trends
- 2.2 Loratadine API Industry Drivers
- 2.3 Loratadine API Industry Opportunities and Challenges
- 2.4 Loratadine API Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Loratadine API Revenue (2021-2026)
- 3.2 Global Top Players by Loratadine API Sales (2021-2026)
- 3.3 Global Top Players by Loratadine API Price (2021-2026)
- 3.4 Global Loratadine API Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Loratadine API Major Company Production Sites & Headquarters
- 3.6 Global Loratadine API Company, Product Type & Application
- 3.7 Global Loratadine API Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Loratadine API Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Loratadine API Players Market Share by Revenue in 2025
- 3.8.3 2025 Loratadine API Tier 1, Tier 2, and Tier 3
4 Loratadine API Regional Status and Outlook
- 4.1 Global Loratadine API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Loratadine API Historic Market Size by Region
- 4.2.1 Global Loratadine API Sales in Volume by Region (2021-2026)
- 4.2.2 Global Loratadine API Sales in Value by Region (2021-2026)
- 4.2.3 Global Loratadine API Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Loratadine API Forecasted Market Size by Region
- 4.3.1 Global Loratadine API Sales in Volume by Region (2027-2032)
- 4.3.2 Global Loratadine API Sales in Value by Region (2027-2032)
- 4.3.3 Global Loratadine API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Loratadine API by Application
- 5.1 Loratadine API Market by Application
- 5.1.1 Loratadine Syrup
- 5.1.2 Loratadine Tablet
- 5.1.3 Loratadine Capsules
- 5.1.4 Dry Suspension
- 5.1.5 Others
- 5.2 Global Loratadine API Market Size by Application
- 5.2.1 Global Loratadine API Market Size Overview by Application (2021-2032)
- 5.2.2 Global Loratadine API Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Loratadine API Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Loratadine API Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Loratadine API Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Loratadine API Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Loratadine API Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Loratadine API Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Shenzhen Salubris Pharmaceuticals
- 6.1.1 Shenzhen Salubris Pharmaceuticals Company Information
- 6.1.2 Shenzhen Salubris Pharmaceuticals Business Overview
- 6.1.3 Shenzhen Salubris Pharmaceuticals Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Shenzhen Salubris Pharmaceuticals Loratadine API Product Portfolio
- 6.1.5 Shenzhen Salubris Pharmaceuticals Recent Developments
- 6.2 Shenzhen Haibin Pharmaceutical
- 6.2.1 Shenzhen Haibin Pharmaceutical Company Information
- 6.2.2 Shenzhen Haibin Pharmaceutical Business Overview
- 6.2.3 Shenzhen Haibin Pharmaceutical Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shenzhen Haibin Pharmaceutical Loratadine API Product Portfolio
- 6.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
- 6.3 Merck Group
- 6.3.1 Merck Group Company Information
- 6.3.2 Merck Group Business Overview
- 6.3.3 Merck Group Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Merck Group Loratadine API Product Portfolio
- 6.3.5 Merck Group Recent Developments
- 6.4 Mylan
- 6.4.1 Mylan Company Information
- 6.4.2 Mylan Business Overview
- 6.4.3 Mylan Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Mylan Loratadine API Product Portfolio
- 6.4.5 Mylan Recent Developments
- 6.5 Shaanxi Hanjiang
- 6.5.1 Shaanxi Hanjiang Company Information
- 6.5.2 Shaanxi Hanjiang Business Overview
- 6.5.3 Shaanxi Hanjiang Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Shaanxi Hanjiang Loratadine API Product Portfolio
- 6.5.5 Shaanxi Hanjiang Recent Developments
- 6.6 Changzhou Yabang
- 6.6.1 Changzhou Yabang Company Information
- 6.6.2 Changzhou Yabang Business Overview
- 6.6.3 Changzhou Yabang Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Changzhou Yabang Loratadine API Product Portfolio
- 6.6.5 Changzhou Yabang Recent Developments
- 6.7 Changzhou Fangyuan Pharmaceutical
- 6.7.1 Changzhou Fangyuan Pharmaceutical Company Information
- 6.7.2 Changzhou Fangyuan Pharmaceutical Business Overview
- 6.7.3 Changzhou Fangyuan Pharmaceutical Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Changzhou Fangyuan Pharmaceutical Loratadine API Product Portfolio
- 6.7.5 Changzhou Fangyuan Pharmaceutical Recent Developments
- 6.8 Vasudha Pharma Chem
- 6.8.1 Vasudha Pharma Chem Company Information
- 6.8.2 Vasudha Pharma Chem Business Overview
- 6.8.3 Vasudha Pharma Chem Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Vasudha Pharma Chem Loratadine API Product Portfolio
- 6.8.5 Vasudha Pharma Chem Recent Developments
- 6.9 Ultratech India Limited
- 6.9.1 Ultratech India Limited Company Information
- 6.9.2 Ultratech India Limited Business Overview
- 6.9.3 Ultratech India Limited Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Ultratech India Limited Loratadine API Product Portfolio
- 6.9.5 Ultratech India Limited Recent Developments
- 6.10 Morepen
- 6.10.1 Morepen Company Information
- 6.10.2 Morepen Business Overview
- 6.10.3 Morepen Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Morepen Loratadine API Product Portfolio
- 6.10.5 Morepen Recent Developments
- 6.11 Inke, S.A.
- 6.11.1 Inke, S.A. Company Information
- 6.11.2 Inke, S.A. Business Overview
- 6.11.3 Inke, S.A. Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Inke, S.A. Loratadine API Product Portfolio
- 6.11.5 Inke, S.A. Recent Developments
- 6.12 Hetero Drugs Ltd
- 6.12.1 Hetero Drugs Ltd Company Information
- 6.12.2 Hetero Drugs Ltd Business Overview
- 6.12.3 Hetero Drugs Ltd Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Hetero Drugs Ltd Loratadine API Product Portfolio
- 6.12.5 Hetero Drugs Ltd Recent Developments
- 6.13 Cadila Pharmaceuticals
- 6.13.1 Cadila Pharmaceuticals Company Information
- 6.13.2 Cadila Pharmaceuticals Business Overview
- 6.13.3 Cadila Pharmaceuticals Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Cadila Pharmaceuticals Loratadine API Product Portfolio
- 6.13.5 Cadila Pharmaceuticals Recent Developments
- 6.14 Argon Drugs
- 6.14.1 Argon Drugs Company Information
- 6.14.2 Argon Drugs Business Overview
- 6.14.3 Argon Drugs Loratadine API Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Argon Drugs Loratadine API Product Portfolio
- 6.14.5 Argon Drugs Recent Developments
7 North America by Country
- 7.1 North America Loratadine API Sales by Country
- 7.1.1 North America Loratadine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Loratadine API Sales by Country (2021-2026)
- 7.1.3 North America Loratadine API Sales Forecast by Country (2027-2032)
- 7.2 North America Loratadine API Market Size by Country
- 7.2.1 North America Loratadine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Loratadine API Market Size by Country (2021-2026)
- 7.2.3 North America Loratadine API Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Loratadine API Sales by Country
- 8.1.1 Europe Loratadine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Loratadine API Sales by Country (2021-2026)
- 8.1.3 Europe Loratadine API Sales Forecast by Country (2027-2032)
- 8.2 Europe Loratadine API Market Size by Country
- 8.2.1 Europe Loratadine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Loratadine API Market Size by Country (2021-2026)
- 8.2.3 Europe Loratadine API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Loratadine API Sales by Country
- 9.1.1 Asia-Pacific Loratadine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Loratadine API Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Loratadine API Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Loratadine API Market Size by Country
- 9.2.1 Asia-Pacific Loratadine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Loratadine API Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Loratadine API Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Loratadine API Sales by Country
- 10.1.1 South America Loratadine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Loratadine API Sales by Country (2021-2026)
- 10.1.3 South America Loratadine API Sales Forecast by Country (2027-2032)
- 10.2 South America Loratadine API Market Size by Country
- 10.2.1 South America Loratadine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Loratadine API Market Size by Country (2021-2026)
- 10.2.3 South America Loratadine API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Loratadine API Sales by Country
- 11.1.1 Middle East and Africa Loratadine API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Loratadine API Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Loratadine API Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Loratadine API Market Size by Country
- 11.2.1 Middle East and Africa Loratadine API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Loratadine API Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Loratadine API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Loratadine API Value Chain Analysis
- 12.1.1 Loratadine API Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Loratadine API Production Mode & Process
- 12.2 Loratadine API Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Loratadine API Distributors
- 12.2.3 Loratadine API Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst